What is the current Inhibitor Therapeutics (QB) share price?
The current share price of Inhibitor Therapeutics (QB) is US$ 0.0601
How many Inhibitor Therapeutics (QB) shares are in issue?
Inhibitor Therapeutics (QB) has 172,323,545 shares in issue
What is the market cap of Inhibitor Therapeutics (QB)?
The market capitalisation of Inhibitor Therapeutics (QB) is USD 10.34M
What is the 1 year trading range for Inhibitor Therapeutics (QB) share price?
Inhibitor Therapeutics (QB) has traded in the range of US$ 0.03355 to US$ 0.1376 during the past year
What is the PE ratio of Inhibitor Therapeutics (QB)?
The price to earnings ratio of Inhibitor Therapeutics (QB) is -3.41
What is the reporting currency for Inhibitor Therapeutics (QB)?
Inhibitor Therapeutics (QB) reports financial results in USD
What is the latest annual profit for Inhibitor Therapeutics (QB)?
The latest annual profit of Inhibitor Therapeutics (QB) is USD -3.03M
What is the registered address of Inhibitor Therapeutics (QB)?
The registered address for Inhibitor Therapeutics (QB) is 108 W. 13TH STREET SUITE 100, WILMINGTON, DELAWARE, 19801
What is the Inhibitor Therapeutics (QB) website address?
The website address for Inhibitor Therapeutics (QB) is www.inhibitortx.com
Which industry sector does Inhibitor Therapeutics (QB) operate in?
Inhibitor Therapeutics (QB) operates in the COML PHYSICAL, BIOLOGCL RESH sector
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
